These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Clinicopathologic characteristics of Burkitt-like lymphoma with chromosome 11q aberration]. Wei P; Zhang YL; Xie JL; Zheng YY; Liu W; Zhou XG Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):176-179. PubMed ID: 29534356 [No Abstract] [Full Text] [Related]
6. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980 [TBL] [Abstract][Full Text] [Related]
7. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752 [TBL] [Abstract][Full Text] [Related]
8. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Gonzalez-Farre B; Ramis-Zaldivar JE; Salmeron-Villalobos J; Balagué O; Celis V; Verdu-Amoros J; Nadeu F; Sábado C; Ferrández A; Garrido M; García-Bragado F; de la Maya MD; Vagace JM; Panizo CM; Astigarraga I; Andrés M; Jaffe ES; Campo E; Salaverria I Haematologica; 2019 Sep; 104(9):1822-1829. PubMed ID: 30733272 [TBL] [Abstract][Full Text] [Related]
9. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma. Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402 [TBL] [Abstract][Full Text] [Related]
10. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438 [TBL] [Abstract][Full Text] [Related]
11. Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification. Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Malawska N; Blachnio K; Bystydzienski Z; Borysiuk A; Nowakowska B; Pienkowska-Grela B Cancer Genet; 2020 Jul; 245():1-5. PubMed ID: 32531723 [TBL] [Abstract][Full Text] [Related]
12. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma. Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902 [TBL] [Abstract][Full Text] [Related]
13. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Salaverria I; Martin-Guerrero I; Wagener R; Kreuz M; Kohler CW; Richter J; Pienkowska-Grela B; Adam P; Burkhardt B; Claviez A; Damm-Welk C; Drexler HG; Hummel M; Jaffe ES; Küppers R; Lefebvre C; Lisfeld J; Löffler M; Macleod RA; Nagel I; Oschlies I; Rosolowski M; Russell RB; Rymkiewicz G; Schindler D; Schlesner M; Scholtysik R; Schwaenen C; Spang R; Szczepanowski M; Trümper L; Vater I; Wessendorf S; Klapper W; Siebert R; ; Blood; 2014 Feb; 123(8):1187-98. PubMed ID: 24398325 [TBL] [Abstract][Full Text] [Related]
14. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Au-Yeung RKH; Arias Padilla L; Zimmermann M; Oschlies I; Siebert R; Woessmann W; Burkhardt B; Klapper W Br J Haematol; 2020 Sep; 190(5):753-763. PubMed ID: 32239695 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification. Szumera-Ciećkiewicz A; Rymkiewicz G; Grygalewicz B; Jesionek-Kupnicka D; Gruchała A; Ziarkiewicz-Wróblewska B; Gałązka K; Reszeć J; Borg K; Prochorec-Sobieszek M Pol J Pathol; 2018; 69(1):1-19. PubMed ID: 29895122 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological and molecular genetic features of Burkitt-like lymphoma with 11q aberration]. Zhang YP; Zhang L; Zhang DD; Wang GN; Zhao WG; Jian XY; Li WC Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):604-608. PubMed ID: 34078047 [No Abstract] [Full Text] [Related]
17. Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker. Hurwitz SN; Lockhart B; Önder Ö; Wu R; Sethi S; Aypar U; Siebert R; Dogan A; Pillai V; Elenitoba-Johnson KSJ; Lim MS Mod Pathol; 2023 Jul; 36(7):100170. PubMed ID: 36997001 [TBL] [Abstract][Full Text] [Related]
18. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770 [TBL] [Abstract][Full Text] [Related]
19. Application of 2016 WHO classification in the diagnosis of paediatric high-grade Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683 [TBL] [Abstract][Full Text] [Related]
20. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases. Shestakova A; Shao L; Smith LB; Ryan R; Bedell V; Murata-Collins J; Zhang W; Perry AM; Song JY Hum Pathol; 2023 Jun; 136():34-43. PubMed ID: 36997031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]